3 completed, 2 recruiting. 4 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Recruiting 2 |
| Phase 3 | 1 | Completed 1 |
Follow Neuroprotective: new trials by email Literature Review of Neuroprotective trials Research Report on Neuroprotective
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interventions for Silent Brain Infarction and Perioperative Neurocognitive Disorders in Cardiovascular Surgery Managements for NeuroFirst target bundle, Managements for institutional routine - Silent Brain Infarction, Neurocognitive Disorders | Not applicable | Recruiting | Chinese Academy of Medical Sciences, Fuwai Hospital | 912 | 2025-07-06 | 2025-11-24 |
| Neuroprotective Effect of (Nano PSO), in Patients Who Used to Consume Psychoactive Substances Nano-PSO, Pomegranate seed oil (omega-5), PLACEBO - Addiction;Drug(S);LSD, Neuroprotective | Not applicable | Recruiting | Distribuidora Biolife SA de CV | 80 | 2024-03-15 | 2024-08-12 |
| Hyperbaric Oxygen Therapy as a Neuroprotective Modality in Pediatric Acquired Brain Injury With Motor Disability Hyperbaric oxygen therapy, Conventional rehabilitation - Hyperbaric Oxygen Therapy, Neuroprotective | Not applicable | Completed | Kafrelsheikh University | 120 | 2024-03-01 | 2025-05-01 |
| Hyperbaric Oxygen Therapy as a Neuroprotective Intervention in Pediatric Acquired Brain Injury With Cognitive Disability Hyperbaric oxygen therapy, Conventional rehabilitation - Hyperbaric Oxygen Therapy, Neuroprotective | Not applicable | Completed | Kafrelsheikh University | 120 | 2024-03-01 | 2025-05-01 |
| Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants Darbepoetin, Placebo - Neurocognitive, Neuroprotective | Phase 3 | Completed | NICHD Neonatal Research Network | 650 | 2017-09-20 | 2026-07-01 |
Brain Injuries (2) · Neurocognitive Disorders (1) · Substance-Related Disorders (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Craniocerebral Trauma (2) · Mental Disorders (2) · Nervous System Diseases (2) · Trauma, Nervous System (2) · Wounds and Injuries (2) · Chemically-Induced Disorders (1)
Hyperbaric Oxygenation (2) · Darbepoetin alfa (1) · Nano-PSO (1) · Nanotechnology (1) · Organization and Administration (1) · Saline Solution (1)
Kafrelsheikh University (2) · Chinese Academy of Medical Sciences, Fuwai Hospital (1) · Distribuidora Biolife SA de CV (1) · NICHD Neonatal Research Network (1)
Egypt (2) · China (1) · Mexico (1) · United States (1)
Irene G Aguilar, PH (1) · Robin Ohls, MD (1)
PMID 10234039, PMID 11333982, PMID 12574402, PMID 15607570, PMID 15664381, PMID 16452669, PMID 16564605, PMID 20456319, PMID 20493211, PMID 20726622, PMID 21885037, PMID 23376567, PMID 23470902, PMID 24376392, PMID 24704590, PMID 24782711, PMID 24961305, PMID 25064020, PMID 25734247, PMID 25999807, PMID 27364743, PMID 27417190, PMID 27810915, PMID 28933310, PMID 29098666, PMID 30317607, PMID 30347311, PMID 30414214, PMID 32899889, PMID 32943651, PMID 32970734, PMID 33371578, PMID 33432157, PMID 34243101, PMID 35159404, PMID 35566074, PMID 35625687, PMID 36812175, PMID 37596391, PMID 40354084, PMID 41392547, PMID 42320960